These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7953636)

  • 1. The effects of amfonelic acid, a dopamine uptake inhibitor, on methamphetamine-induced dopaminergic terminal degeneration and astrocytic response in rat striatum.
    Pu C; Fisher JE; Cappon GD; Vorhees CV
    Brain Res; 1994 Jun; 649(1-2):217-24. PubMed ID: 7953636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methamphetamine and human immunodeficiency virus protein Tat synergize to destroy dopaminergic terminals in the rat striatum.
    Theodore S; Cass WA; Maragos WF
    Neuroscience; 2006 Feb; 137(3):925-35. PubMed ID: 16338084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of MK-801 on methamphetamine-induced depletion of dopaminergic and serotonergic terminals and striatal astrocytic response: an immunohistochemical study.
    Pu C; Vorhees CV
    Synapse; 1995 Feb; 19(2):97-104. PubMed ID: 7725247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Damage to dopaminergic nerve terminals in mice by combined treatment of intrastriatal malonate with systemic methamphetamine or MPTP.
    Albers DS; Zeevalk GD; Sonsalla PK
    Brain Res; 1996 Apr; 718(1-2):217-20. PubMed ID: 8773791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of monoamine uptake inhibitors and methamphetamine on neostriatal 6-hydroxydopamine (6-OHDA) formation, short-term monoamine depletions and locomotor activity in the rat.
    Marek GJ; Vosmer G; Seiden LS
    Brain Res; 1990 May; 516(1):1-7. PubMed ID: 2142010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single or multiple injections of methamphetamine increased dopamine turnover but did not decrease tyrosine hydroxylase levels or cleave caspase-3 in caudate-putamen.
    Pereira FC; Lourenço ES; Borges F; Morgadinho T; Ribeiro CF; Macedo TR; Ali SF
    Synapse; 2006 Sep; 60(3):185-93. PubMed ID: 16739116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inhibition of cyclooxygenase-2 exacerbates methamphetamine-induced dopamine depletion in the striatum in rats.
    Zhang X; Dong F; Mayer GE; Bruch DC; Ren J; Culver B
    Neuroscience; 2007 Dec; 150(4):950-8. PubMed ID: 17988800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the dopamine uptake carrier in the neurochemical response to methamphetamine: effects of amfonelic acid.
    Schmidt CJ; Gibb JW
    Eur J Pharmacol; 1985 Feb; 109(1):73-80. PubMed ID: 2581794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental dissociation of methamphetamine-induced depletion of dopaminergic terminals and astrocyte reaction in rat striatum.
    Pu C; Vorhees CV
    Brain Res Dev Brain Res; 1993 Apr; 72(2):325-8. PubMed ID: 8097974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotinamide attenuates methamphetamine-induced striatal dopamine depletion in rats.
    Huang NK; Wan FJ; Tseng CJ; Tung CS
    Neuroreport; 1997 May; 8(8):1883-5. PubMed ID: 9223070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of methamphetamine on glutamate-positive neurons in the adult and developing rat somatosensory cortex.
    Pu C; Broening HW; Vorhees CV
    Synapse; 1996 Aug; 23(4):328-34. PubMed ID: 8855518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deprenyl induces GFAP immunoreactivity in the intact and injured dopaminergic nigrostriatal system but fails to counteract axotomy-induced degenerative changes.
    Revuelta M; Venero JL; Machado A; Cano J
    Glia; 1997 Oct; 21(2):204-16. PubMed ID: 9336235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of estrogen and related agents upon methamphetamine-induced neurotoxicity within an impaired nigrostriatal dopaminergic system of ovariectomized mice.
    Liu B; Dluzen DE
    Neuroendocrinology; 2006; 83(5-6):295-302. PubMed ID: 16926530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced degeneration of dopaminergic terminals and accentuated astrocyte activation by high dose methamphetamine administration in nociceptin receptor knock out mice.
    Sakoori K; Murphy NP
    Neurosci Lett; 2010 Jan; 469(3):309-13. PubMed ID: 20025929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine uptake inhibitors block long-term neurotoxic effects of methamphetamine upon dopaminergic neurons.
    Marek GJ; Vosmer G; Seiden LS
    Brain Res; 1990 Apr; 513(2):274-9. PubMed ID: 2140952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers.
    Killinger BA; Moszczynska A
    J Neurochem; 2016 Feb; 136(3):510-25. PubMed ID: 26465779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine transporter as a marker of neuroprotection in methamphetamine-lesioned mice treated acutely with estradiol.
    D'Astous M; Gajjar TM; Dluzen DE; Di Paolo T
    Neuroendocrinology; 2004; 79(6):296-304. PubMed ID: 15249736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methamphetamine-induced modification of dopamine metabolism in cultured striatal astrocytes.
    Kita T; Philbert MA; Wagner GC; Huang J; Lowndes HE
    Pharmacol Toxicol; 1998 Jul; 83(1):36-9. PubMed ID: 9764424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute effects of estrogen upon methamphetamine induced neurotoxicity of the nigrostriatal dopaminergic system.
    Gajjar TM; Anderson LI; Dluzen DE
    J Neural Transm (Vienna); 2003 Nov; 110(11):1215-24. PubMed ID: 14628187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nomifensine alters sex differences in striatal dopaminergic function.
    Poth LS; O'Connell BP; McDermott JL; Dluzen DE
    Synapse; 2012 Aug; 66(8):686-93. PubMed ID: 22389194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.